Real-time enrollment status for this breast neoplasms clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:09 PM UTC
| NCT Number | NCT02701244 |
| Recruiting Status | Recruiting |
| Condition | Breast Neoplasms |
| Phase | Clinical Trial |
| Target Enrollment | 420 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Concure Oncology-Breast Microseed Inc. |
| Last Updated on CT.gov | March 19, 2018 (Mar 19, 2018) |
As of July 13, 2026: Clinical trial NCT02701244 is currently recruiting participants. This clinical trial study for breast neoplasms is actively seeking new participants at 3 locations across the United States. The study is sponsored by Concure Oncology-Breast Microseed Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02701244 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02701244 was last updated Mar 19, 2018 (March 19, 2018). HelloStudys verifies this status automatically.